Home Contact Sitemap Glossary Search
Go
XOMA - A Leader in Therapeutic Antibodies

   
  SEC Filings Investors
 
Print Print page   Email Email page

Stock Information
XOMA - (NASD)
$2.08   - 0.07
May 13, 2008
2:35 PM ET


Quotes delayed at least 20 minutes.
Information provided by TurboFeed.

 
     
Add to Briefcase = Add Filing to Briefcase
Filing Description Date Filed Sorted Descending Size  
10-Q quarterly report May 12, 2008 477.9 KB Add to Briefcase
8-K current report May 12, 2008 44.6 KB Add to Briefcase
8-K current report Apr 9, 2008 28.0 KB Add to Briefcase
DEF 14A definitive proxy statement Apr 9, 2008 344.1 KB Add to Briefcase
8-K current report Apr 2, 2008 36.3 KB Add to Briefcase
10-K/A amended annual report Mar 14, 2008 90.2 KB Add to Briefcase
8-K current report Mar 14, 2008 18.7 KB Add to Briefcase
10-K annual report Mar 11, 2008 1.3 MB Add to Briefcase
4 scannon, patrick j md phd Feb 25, 2008 19.8 KB Add to Briefcase
4 margolin, christopher j Feb 25, 2008 24.9 KB Add to Briefcase
4 engle, steven b Feb 25, 2008 24.7 KB Add to Briefcase
4 boyle, j david ii Feb 25, 2008 19.8 KB Add to Briefcase
4 zenner, patrick j Feb 25, 2008 24.0 KB Add to Briefcase
4 hutt, peter barton Feb 25, 2008 19.0 KB Add to Briefcase
4 van, ness w denman Feb 25, 2008 24.0 KB Add to Briefcase
4 fisher, charles j jr Feb 25, 2008 19.0 KB Add to Briefcase
4 bowes, william k jr Feb 25, 2008 19.0 KB Add to Briefcase
4 andress, james g Feb 25, 2008 19.0 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2008 59.6 KB Add to Briefcase
5 scannon patrick j md phd Feb 11, 2008 25.7 KB Add to Briefcase
Showing 1-20 of 343 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  See Next 20